# EDGAR Filing Document

**Accession Number:** 0001713090
**File Stem:** 0001077183-25-000129
**Filing Date:** 2025-6
**Character Count:** 6883
**Document Hash:** 077f27c84c4b8edb8aa0cb544fcc6f0f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001077183-25-000129.hdr.sgml**: 20250603

**ACCESSION NUMBER**: 0001077183-25-000129

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250601

**FILED AS OF DATE**: 20250603

**DATE AS OF CHANGE**: 20250603

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** KANOVSKY STEPHEN M
- **CENTRAL INDEX KEY:** 0001713090

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35756
- **FILM NUMBER:** 251019488

**MAIL ADDRESS:**
- **STREET 1:** 88 OLD YORK ROAD
- **CITY:** NEW HOPE
- **STATE:** PA
- **ZIP:** 18938
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NEOGENOMICS INC
- **CENTRAL INDEX KEY:** 0001077183
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-TESTING LABORATORIES [8734]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 742897368
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 9490 NEOGENOMICS WAY
- **CITY:** FORT MYERS
- **STATE:** FL
- **ZIP:** 33912
- **BUSINESS PHONE:** 2397680600

**MAIL ADDRESS:**
- **STREET 1:** 9490 NEOGENOMICS WAY
- **CITY:** FORT MYERS
- **STATE:** FL
- **ZIP:** 33912

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AMERICAN COMMUNICATIONS ENTERPRISES INC
- **DATE OF NAME CHANGE:** 19990120

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>KANOVSKY STEPHEN M<br><sub>(Last) (First) (Middle)</sub><br>9490 NEOGENOMICS WAY<br><sub>(Street)</sub><br>FORT MYERS, FL 33912<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-01 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>NEOGENOMICS INC [ NEO ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-06-01 |  | M |  | 12254<sup>(1)</sup> | A | $0 | 52344 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Unit | $0 | 2025-06-01 |  | M |  |  | 12254 | 2025-06-01 | <sup>(2)</sup> | Common Stock | 12254 | $0 | 0 | D |  |
| Stock Option  (Right to Buy) | $7.28 | 2025-06-01 |  | A |  | 16107 |  | 2026-06-01 | 2035-06-01 | Common Stock | 16107 | $0 | 16107 | D |  |
| Restricted Stock Unit | $0 | 2025-06-01 |  | A |  | 23077 |  | 2026-06-01 | <sup>(2)</sup> | Common Stock | 23077 | $0 | 23077 | D |  |
| Stock Option  (Right to Buy) | $22.52 |  |  |  |  |  |  | 2020-06-06 | 2026-06-06 | Common Stock | 4269 |  | 4269 | D |  |
| Stock Option  (Right to Buy) | $28.54 |  |  |  |  |  |  | 2021-05-28 | 2027-05-28 | Common Stock | 3448 |  | 3448 | D |  |
| Stock Option  (Right to Buy) | $40.90 |  |  |  |  |  |  | 2022-06-02 | 2028-06-02 | Common Stock | 3714 |  | 3714 | D |  |
| Stock Option  (Right to Buy) | $8.10 |  |  |  |  |  |  | 2023-06-10 | 2029-06-10 | Common Stock | 13882 |  | 13882 | D |  |
| Stock Option  (Right to Buy) | $14.82 |  |  |  |  |  |  | 2024-08-10 | 2033-08-10 | Common Stock | 8353 |  | 8353 | D |  |
| Stock Option  (Right to Buy) | $13.71 |  |  |  |  |  |  | 2025-06-01 | 2034-06-01 | Common Stock | 8672 |  | 8672 | D |  |

---

### Footnotes:

(1) Reflects release of restricted stock units that were previously reported on a Form 4.

(2) Once vested, the shares of common stock are not subject to expiration.

**Signature:** /s/ Ali Olivo, Attorney-in-Fact  
**Date:** 2025-06-03

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**